Findings of Research Misconduct, 18638 [2015-07896]

Download as PDF 18638 Federal Register / Vol. 80, No. 66 / Tuesday, April 7, 2015 / Notices RECORD SOURCE CATEGORIES: Records are obtained directly from the subject individuals, or from the following sources: educational institutions; internship and/or residency training programs; employers; NHSCapproved service sites; critical shortage facilities; schools of nursing; lending institutions and loan servicing agencies; health professional associations; National Practitioner Data Bank; System for Awards Management (formerly Excluded Parties List System); HHS Office of Inspector General Web site listing of individuals excluded from Medicare, Medicaid, and all other federal health care programs; HHS database of Health Professional Shortage Areas; HHS grantees and contractors/ subcontractors; consumer reporting agencies/credit bureaus; other federal agencies, including but not limited to the Department of the Treasury, IRS, and the U.S. Postal Service; state health professions licensing boards and/or the Federation of State Medical Boards or a similar non-government entity; and third parties who provide references or other information concerning the subject individual. SYSTEM EXEMPTED FROM CERTAIN PROVISIONS OF THE ACT: None. [FR Doc. 2015–07899 Filed 4–6–15; 8:45 am] BILLING CODE CODE 4160–15–P DEPARTMENT OF HEALTH AND HUMAN SERVICES Office of the Secretary Findings of Research Misconduct Office of the Secretary, HHS. Notice. AGENCY: ACTION: Notice is hereby given that the Office of Research Integrity (ORI) has taken final action in the following case: Teresita L. Briones, Ph.D., Wayne State University: Based on the report of an inquiry conducted by Wayne State University (WSU) and additional analysis conducted by ORI in its oversight review, ORI found that Dr. Teresita L. Briones, former Associate Professor, College of Nursing, WSU, engaged in research misconduct in research supported by National Institute of Nursing Research (NINR), National Institutes of Health (NIH), grants P30 NR009014, R01 NR005260, and R01 NR007666. ORI found that Respondent intentionally, knowingly, and recklessly engaged in research misconduct by falsifying and/or fabricating data that mstockstill on DSK4VPTVN1PROD with NOTICES SUMMARY: VerDate Sep<11>2014 17:46 Apr 06, 2015 Jkt 235001 were included in five (5) publications and three (3) grant applications submitted to NINR, NIH: Behavioural Brain Research 279:112–22, 2015 Feb 15 (hereafter referred to as ‘‘BBR 2015’’) • Journal of Neuroinflammation 11:13, 2014 Jan 22 (hereafter referred to as ‘‘JNI 2014’’) • Journal of Neurotrauma 26(4):613–25, 2009 Apr (hereafter referred to as ‘‘JNT 2009’’) • Journal of Neurotrauma 28(12):2485– 92, 2011 Dec (hereafter referred to as ‘‘JNT 2011’’) • Neuroscience 262:143–55, 2014 Mar 14 (hereafter referred to as ‘‘NS 2014’’) • R01 NR011167–01 • R01 NR011167–01A1 • R01 NR 011167–01A2 ORI found that Respondent falsified and/or fabricated data by falsely reporting the results of Western blot experiments that examined neuroinflammation, amyloidogenesis, and/or cognitive impairment in a rat model of cerebral ischemia. Specifically, Respondent duplicated, reused, and falsely relabeled Western blot gel images and claimed they represented different experiments in: • BBR 2015, Figures 2E and 5D • JNI 2014, Figures 2A and 2C • JNT 2009, Figures 2B and 5 • JNT 2011, Figure 2 • NS 2014, Figure 4 • R01 NR011167–01, Figures 5 and 6 • R01 NR011167–01A1, Figures 4A and 4B • R01 NR011167–01A2, Figures 4A and 4B As a result of this Agreement, Respondent will request that the following publications be retracted: BBR 2015, JNI 2014, JNT 2009, JNT 2011, and NS 2014. Dr. Briones has entered into a Voluntary Exclusion Agreement (Agreement) and has voluntarily agreed for a period of three (3) years, beginning on March 12, 2015: (1) to exclude herself from any contracting or subcontracting with any agency of the United States Government and from eligibility for or involvement in nonprocurement programs of the United States Government referred to as ‘‘covered transactions’’ pursuant to HHS’ Implementation (2 CFR part 376 et seq) of OMB Guidelines to Agencies on Governmentwide Debarment and Suspension, 2 CFR part 180 (collectively the ‘‘Debarment Regulations’’); (2) to exclude herself voluntarily from serving in any advisory capacity to the U.S. Public Health Service (PHS) including, but not limited to, service on any PHS advisory committee, board, PO 00000 Frm 00053 Fmt 4703 Sfmt 4703 and/or peer review committee, or as a consultant; and (3) to request that the following publications be retracted: BBR 2015, JNI 2014, JNT 2009, JNT 2011, and NS 2014. FOR FURTHER INFORMATION CONTACT: Acting Director, Office of Research Integrity, 1101 Wootton Parkway, Suite 750, Rockville, MD 20852, (240) 453– 8200. Donald Wright, Acting Director, Office of Research Integrity. [FR Doc. 2015–07896 Filed 4–6–15; 8:45 am] BILLING CODE CODE 4150–31–P DEPARTMENT OF HEALTH AND HUMAN SERVICES Office of the Secretary Findings of Research Misconduct Office of the Secretary, HHS. Notice. AGENCY: ACTION: Notice is hereby given that the Office of Research Integrity (ORI) has taken final action in the following case: Ryousuke Fujita, Ph.D., Columbia University: Based on the report of an investigation conducted by Columbia University (CU) and additional analysis conducted by ORI in its oversight review, ORI found that Dr. Ryousuke Fujita, former Postdoctoral Scientist, Taub Institute for the Aging Brain, Departments of Pathology and Cell Biology and Neurology, CU Medical Center, engaged in research misconduct in research supported by National Institute of Neurological Disorders and Stroke (NINDS), National Institutes of Health (NIH), grant R01 NS064433 and National Institute of Aging (NIA), NIH, grant R01 AG042317. ORI found that Respondent engaged in research misconduct by falsifying and fabricating data for specific protein expressions in human-induced neuronal (hiN) cells derived skin fibroblasts of Alzheimer’s disease patients and unaffected individuals in seventy-four (74) panels included in figures in the following two (2) publications and one (1) unpublished manuscript: • Cell 146:359–371, 2011 (hereafter referred to as ‘‘Cell 2011’’). • Nature 500:45–53, 2013 (hereafter referred to as ‘‘Nature 2013’’). • ‘‘Human induced neuron models of APOE4-associated Alzheimer’s disease display altered APP endocytosis and processing.’’ Unpublished manuscript. ORI found that Respondent engaged in research misconduct by knowingly and intentionally fabricating and falsifying research in seventy-four (74) SUMMARY: E:\FR\FM\07APN1.SGM 07APN1

Agencies

[Federal Register Volume 80, Number 66 (Tuesday, April 7, 2015)]
[Notices]
[Page 18638]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2015-07896]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Office of the Secretary


Findings of Research Misconduct

AGENCY: Office of the Secretary, HHS.

ACTION: Notice.

-----------------------------------------------------------------------

SUMMARY: Notice is hereby given that the Office of Research Integrity 
(ORI) has taken final action in the following case:
    Teresita L. Briones, Ph.D., Wayne State University: Based on the 
report of an inquiry conducted by Wayne State University (WSU) and 
additional analysis conducted by ORI in its oversight review, ORI found 
that Dr. Teresita L. Briones, former Associate Professor, College of 
Nursing, WSU, engaged in research misconduct in research supported by 
National Institute of Nursing Research (NINR), National Institutes of 
Health (NIH), grants P30 NR009014, R01 NR005260, and R01 NR007666.
    ORI found that Respondent intentionally, knowingly, and recklessly 
engaged in research misconduct by falsifying and/or fabricating data 
that were included in five (5) publications and three (3) grant 
applications submitted to NINR, NIH:

Behavioural Brain Research 279:112-22, 2015 Feb 15 (hereafter referred 
to as ``BBR 2015'')
 Journal of Neuroinflammation 11:13, 2014 Jan 22 (hereafter 
referred to as ``JNI 2014'')
 Journal of Neurotrauma 26(4):613-25, 2009 Apr (hereafter 
referred to as ``JNT 2009'')
 Journal of Neurotrauma 28(12):2485-92, 2011 Dec (hereafter 
referred to as ``JNT 2011'')
 Neuroscience 262:143-55, 2014 Mar 14 (hereafter referred to as 
``NS 2014'')
 R01 NR011167-01
 R01 NR011167-01A1
 R01 NR 011167-01A2

    ORI found that Respondent falsified and/or fabricated data by 
falsely reporting the results of Western blot experiments that examined 
neuroinflammation, amyloidogenesis, and/or cognitive impairment in a 
rat model of cerebral ischemia. Specifically, Respondent duplicated, 
reused, and falsely relabeled Western blot gel images and claimed they 
represented different experiments in:

 BBR 2015, Figures 2E and 5D
 JNI 2014, Figures 2A and 2C
 JNT 2009, Figures 2B and 5
 JNT 2011, Figure 2
 NS 2014, Figure 4
 R01 NR011167-01, Figures 5 and 6
 R01 NR011167-01A1, Figures 4A and 4B
 R01 NR011167-01A2, Figures 4A and 4B

    As a result of this Agreement, Respondent will request that the 
following publications be retracted: BBR 2015, JNI 2014, JNT 2009, JNT 
2011, and NS 2014.
    Dr. Briones has entered into a Voluntary Exclusion Agreement 
(Agreement) and has voluntarily agreed for a period of three (3) years, 
beginning on March 12, 2015:
    (1) to exclude herself from any contracting or subcontracting with 
any agency of the United States Government and from eligibility for or 
involvement in nonprocurement programs of the United States Government 
referred to as ``covered transactions'' pursuant to HHS' Implementation 
(2 CFR part 376 et seq) of OMB Guidelines to Agencies on Governmentwide 
Debarment and Suspension, 2 CFR part 180 (collectively the ``Debarment 
Regulations'');
    (2) to exclude herself voluntarily from serving in any advisory 
capacity to the U.S. Public Health Service (PHS) including, but not 
limited to, service on any PHS advisory committee, board, and/or peer 
review committee, or as a consultant; and
    (3) to request that the following publications be retracted: BBR 
2015, JNI 2014, JNT 2009, JNT 2011, and NS 2014.

FOR FURTHER INFORMATION CONTACT: Acting Director, Office of Research 
Integrity, 1101 Wootton Parkway, Suite 750, Rockville, MD 20852, (240) 
453-8200.

Donald Wright,
Acting Director, Office of Research Integrity.
[FR Doc. 2015-07896 Filed 4-6-15; 8:45 am]
BILLING CODE CODE 4150-31-P

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.